This guidelines applies to health product. The objectives for issuing this Administrative Order are to simplify the requirements and processes for initial, renewal, and variation of License to Operate (LTO) applications and to re-engineer and streamline the FDA’s processes and automate its system in compliance with the provisions of RA 11032 in the maximum prescribed processing time depending on the complexity of the transaction.
Content
Rationale
Objectives
Scope and Coverage
Definition of Terms
General Guidelines
Specific Guidelines
Penalty Clause
Repealing Clause
Separability Clause
Effectivity